Exercise and Pain in CCS
Exercise Intervention Coupled With Standard Post-cancer Directed Treatment Care to Reduce Chronic Pain in Childhood Cancer Survivors Who Have Completed Cancer-directed Therapy Less Than One Year
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this study is to demonstrate that integration of exercise intervention into standard post-cancer directed treatment care will improve patient reported pain, decrease the need for medications to manage chronic pain and improve functional and psychosocial outcomes in survivors of cancers in children and adolescents. Our central hypothesis is that integration of exercise interventions into standard post-cancer directed treatment care will be acceptable and feasible while improving patients' pain, decreasing the cumulative dose of pain medication and improving patients' functional and psychosocial outcomes as compared to patients who only receive standard post-cancer directed treatment care.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 26, 2022
CompletedFirst Posted
Study publicly available on registry
September 30, 2022
CompletedStudy Start
First participant enrolled
September 30, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 11, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 11, 2025
CompletedMay 14, 2025
May 1, 2025
2.4 years
September 26, 2022
May 8, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Acceptability of the intervention
The number of participants approached who agree to participate in the study
Baseline
Feasibility of the intervention
The number of participants randomized to the physical activity program intervention coupled with standard post-cancer directed treatment care who complete at least 50% of the physical activity intervention.
Baseline to week 16
Secondary Outcomes (8)
Measure changes in chronic pain levels
Baseline, week 8 and week 16
Measure changes in cumulative dose of pain medications
Baseline, week 4, week 8, week 12 and week 16
Measure changes in patient reported outcomes
Baseline, week 8 and week 16
Measure changes in physical activity level
Baseline, week 8 and week 16
Measure changes in patient functional outcomes (6-min walking test)
Baseline and week 16
- +3 more secondary outcomes
Study Arms (2)
Physical activity intervention coupled with standard post-cancer directed treatment care group
EXPERIMENTALStandard post-cancer directed treatment care control group
OTHERInterventions
CCS will participate in a 16-week physical activity program. CCS will be instructed to start with a session duration of \<15-min, three days per week at low intensity (e.g., activities expending \>1.5 to 3 METs or intensity \<5 on a scale of 0 to 10). Any type of physical activity will be acceptable. The program will be individualized, and activity increased according to patients' health status, results from the physical function assessment, and most recent week's achieved physical activities. The program will include support calls and texts from research staff (exercise physiologist). The program will be modified and adapted during support calls or texts, including frequency, intensity, time and type to maximize CCS' success. CCS will receive a Fitbit at the beginning of the intervention.
CCS in the control group will not participate in a 16-week physical activity program and will not receive support calls or texts. Physical activity advice according to the Children's Oncology Group Guidelines for Diet and Physical Activity recommendations and the International Pediatric Oncology Exercise Guidelines will be offered to CCS following completion of 16-week follow-up. Moreover, CCS will receive a Fitbit following completion of 16-week follow-up
Eligibility Criteria
You may qualify if:
- Male and female CCS diagnosed with any type of cancer
- CCS who have completed all standard/planned cancer treatment and are stable at the time of recruitment
- CCS are \< 1-year post cancer therapy
- CCS who have chronic pain (pain will be self-reported by the participant, will have to be ≥1 on a scale of 10 and lasting for 3 months or longer)
- CCS who are age between 10 and 17 years old at the time of enrollment
- CCS who are and who are not non-ambulatory/wheelchair bound.
- CCS and parent/legal guardian must be able to speak, read and understand the English language
- CCS's parent or legal guardian must be able to provide and understand informed consent
- CCS must be able to provide and understand assent
- CCS must be able to attend three visits (baseline, 8 and 16-week follow-up) at the Penn State Health Children's Hospital
- CCS and parent/legal guardian must have access to a computer, smartphone or tablet
- Note: The agreement of the attending oncologist will be required for the participation of CCS eligible for this study.
You may not qualify if:
- CCS who have not completed all standard/planned cancer treatment and/or not in complete remission at the time of recruitment
- CCS who are \> 1-year post cancer therapy
- CCS who are \< 10 years old and \> 17 years old at the time of enrollment
- CCS who have history of refractory or recurrent cancer
- CCS or their parent/legal guardian who are unable to speak, read, and understand the English language
- CCS who are unable to access and complete online questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Penn State Health Children's Hospital
Hershey, Pennsylvania, 17033, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Smita Dandekar, MD
Penn State College of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Smita Dandekar, MD
Study Record Dates
First Submitted
September 26, 2022
First Posted
September 30, 2022
Study Start
September 30, 2022
Primary Completion
March 11, 2025
Study Completion
March 11, 2025
Last Updated
May 14, 2025
Record last verified: 2025-05